Brugada Syndrome

Brugada syndrome is a rare but serious genetic condition that affects the heart's electrical system. It increases the risk of dangerous arrhythmias and sudden cardiac arrest, especially during sleep or rest. The condition is often inherited and can go undiagnosed until symptoms appear or a family member is affected - most often caused by genetic mutations that affect the heart’s sodium channels, disrupting its electrical activity.

Brugada syndrome is categorized by its electrocardiogram (ECG) patterns:

• Type 1 (Classic Brugada Pattern) – Diagnostic; shows a distinctive “coved” ST segment elevation.
• Type 2 and 3 –May resemble Brugada but are not diagnostic on their own. Diagnosis often requires a combination of ECG findings, clinical history, and sometimes medication testing to provoke the pattern.

Brugada syndrome is usually inherited in an autosomal dominant pattern, meaning only one copy of the mutated gene is needed to increase risk. Risk factors include:

• Family history of Brugada syndrome or sudden cardiac death
• SCN5A gene mutation (most common genetic link)
• Male gender – Men are more frequently affected
• Fever – Can trigger abnormal heart rhythms in individuals with brugada
• Certain medications – Including some antiarrhythmics and antidepressants can trigger arrhythmias in individuals with Brugada syndrome.

Many people with Brugada syndrome are asymptomatic. When symptoms do occur, they may include:

• Fainting (syncope), especially during rest or sleep
• Seizure-like activity
• Irregular or racing heartbeats
• Sudden cardiac arrest

Brugada syndrome is one of the leading causes of sudden cardiac death in young, otherwise healthy adults.

Diagnosis often involves:

• Electrocardiogram (ECG) – Key test showing a specific electrical pattern of the heart known as “Brugada pattern”.
• Provocation Testing – Medication may be used to trigger and reveal ECG changes that is seen with Brugada syndrome.
• Genetic Testing – May confirm inherited mutations, especially for family screening.
• Electrophysiology Study (EPS) – In some cases, doctors may perform a procedure to test the hearts electrical system to assess the risk of dangerous arrhythmias.

If Brugada is suspected, immediate evaluation by a cardiac electrophysiologist is essential.

Treatment is focused on preventing sudden cardiac arrest and managing arrhythmias:

• Implantable Cardioverter Defibrillator (ICD) – Most effective for preventing sudden death. This device monitors the heart rhythm and delivers a shock when a dangerous arrhythmia is detected.
• Avoiding Triggers – Such as fever, certain medications, and electrolyte imbalances.
• Medications – Drugs like quinidine may be used in specific cases to stabilize the heart’s rhythm.
• Regular Monitoring – For individuals at low to moderate risk, no treatment is required but regular follow-up with a cardiologist is recommended.

If untreated, Brugada syndrome can result in:

• Sudden Cardiac Arrest
• Recurrent fainting or seizures
• Ventricular fibrillation – A fatal heart rhythm
• Emotional and psychological stress – Due to the unpredictability of symptoms

There’s no known way to prevent Brugada syndrome itself, but you can reduce risk by:

• Getting regular heart checkups if you have a family history
• Avoiding medications known to trigger arrhythmias
• Treating fevers promptly
• Considering genetic testing for family members